We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Siemens Healthineers - Laboratory Diagnostics

Siemens Healthineers - Laboratory Diagnostics

Provides advanced laboratory diagnostics solutions for the medical industry read more Featured Products: More products

Download Mobile App




Compact Immunoassay and Clinical Chemistry Analyzer Helps Low- to Mid-Volume Labs Tackle Challenges

By LabMedica International staff writers
Posted on 21 Jul 2023
Print article
Image: The Atellica CI Analyzer offers the highest throughput in the smallest footprint (Photo courtesy of Siemens)
Image: The Atellica CI Analyzer offers the highest throughput in the smallest footprint (Photo courtesy of Siemens)

Clinical laboratories face crucial operational challenges that hinder productivity, such as an increased number of patient samples, staff shortages, and additional documentation requirements. Now, a new immunoassay and clinical chemistry testing system is designed to address these issues related to labor shortages, while also promoting revenue growth and enhancing agility beyond standardization and clinical equivalence. Workflow improvements offered by this system can aid laboratories in achieving more predictable turnaround times, reducing reporting duties, and allowing staff to concentrate on essential lab operations.

Every lab, irrespective of its size, grapples with significant challenges arising from labor shortages. These range from ensuring reliable test results to facilitating predictable care, protecting staff, securing data, and achieving environmental objectives. The Atellica CI Analyzer from Siemens Healthineers (Erlangen, Germany) enables both standalone labs and satellite labs of wider health networks to access the same reagents, consumables, and intelligent software as the company's flagship Atellica Solution, but now in a compact 1.9 square meters footprint ideal for smaller laboratories. Labs with low to medium testing volumes will appreciate the competitive edge offered by the Atellica CI Analyzer, including improved turnaround time predictability, advanced reporting functionality, and robust safety and security measures.

Designed with standout capabilities, the Atellica CI Analyzer maximizes downtime usage and bolsters lab efficiency and profitability. Features like random access sampling, micro-volume aspiration, and automatic scheduling for maintenance and quality control enable labs to deliver more predictable sample turnaround times. The independent operation of chemistry and immunoassay engines ensures that throughput isn't compromised if one of the two needs to be halted. In addition to producing patient results, labs also need to meet reporting requirements, address cybersecurity, and achieve staff satisfaction goals. The Atellica CI Analyzer comes with the Atellica Laboratory Evaluation Suite to provide inspection-ready reports, helping labs meet accreditation guidelines without requiring additional software and allowing laboratory staff to redirect their efforts toward other important lab operations. Increased security measures are also available, including user authentication, role-based authorizations, and audit trails. With a planned menu of over 200 assays spanning 20 disease states, each lab in a health network can select the best tests for its patient population, fulfilling clinical needs that might otherwise be unmet. More than 50 key assays can produce results in less than 14 minutes.

"Workflow standardization and clinical equivalence are critical components of a successful laboratory operation within a health network. The Atellica CI Analyzer elevates laboratory operations to a new level of agility," said Sharon Bracken, head of Diagnostics for Siemens Healthineers. "Labs today need testing instrumentation and informatics that can easily keep pace with rapidly changing testing demands as they occur. This next-generation laboratory analyzer anticipates workflow bottlenecks, mitigates them proactively, and delivers insights based on data that help laboratory staff do their job more effectively and efficiently."

Related Links:
Siemens Healthineers 

New
Platinum Supplier
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
New
Gold Supplier
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
New
Filaria ELISA Test
Filaria IgG-4 ELISA Kit
New
Self-Sampling Terminal
NOVALab

Print article
GLOBETECH PUBLISHING LLC

Channels

Molecular Diagnostics

view channel
Image: A CRISPR technology-based diagnostic test detects MPXV in clinical samples with acute precision (Photo courtesy of 123RF)

Powerful Diagnostic Tool Accurately Detects Monkeypox Virus Faster Than Any Method

At present, testing for the monkeypox virus (MPXV) is done mainly in centralized labs, and it can take days to get results due to location and logistical issues. Now, researchers have leveraged cutting-edge... Read more

Hematology

view channel
Image: The US FDA has cleared HemoScreen point of care CBC for direct capillary sampling (Photo courtesy of PixCell Medical)

Point of Care CBC Analyzer with Direct Capillary Sampling Enhances Ease-of-Use and Testing Throughput

The world’s only 5-part differential Complete Blood Count (CBC) analyzer that is FDA-cleared, CE-marked, and TGA-approved for point-of-care use has now been granted FDA 510(k) clearance for direct capillary... Read more

Immunology

view channel
Image: Immune cells present long before infection predict flu symptoms (Photo courtesy of Shutterstock.com)

Single Blood Draw to Detect Immune Cells Present Months before Flu Infection Can Predict Symptoms

For decades, if not centuries, scientists have struggled to solve the mystery of why certain individuals fall ill to infections while others remain unaffected. In an impressive development, researchers... Read more

Microbiology

view channel
Image: The rapid diagnostic test could pinpoint the correct antibiotic for infection treatment in under an hour (Photo courtesy of Microplate Dx)

Point-of-Care Device to Reduce Antibiotic Susceptibility Testing Time from Days to Minutes

Antimicrobial resistance (AMR) is a significant global health issue, currently leading to over 1.27 million deaths worldwide each year. By 2050, AMR could be causing up to 10 million deaths annually, surpassing... Read more

Pathology

view channel
Image: The Tasso+ device has received CE Mark certification (Photo courtesy of Tasso)

Groundbreaking Blood Lancing Device Obtains Microliter Capillary Whole Blood Samples Painlessly

A convenient, virtually pain-free blood lancet that collects whole liquid blood samples has received CE Mark designation, making the patient-centric, high-volume blood collection solution available in... Read more

Technology

view channel
Image: A new electrochemical device can quickly and inexpensively identify people at greatest risk for osteoporosis (Photo courtesy of ACS Central Science, 2023)

Electrochemical Device Identifies People at Higher Risk for Osteoporosis Using Single Blood Drop

With the global increase in life expectancy, the incidence of age-related conditions like osteoporosis is increasing. Osteoporosis, affecting around 200 million individuals worldwide, has a higher incidence... Read more

Industry

view channel
Image: The global fully automatic electrolyte analyzers market is projected to reach close to USD 0.77 billion by 2032 (Photo courtesy of 123RF)

Global Fully Automatic Electrolyte Analyzers Market Driven by Surge in Demand for Point-of-Care Testing

Fully automatic electrolyte analyzers can measure the levels of electrolytes in various bodily fluids like blood and plasma. Electrolytes are ions that have an electrical charge and are essential for multiple... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.